Image Features of LSCI and Thermography for Determining the Risk Factor (0,1,2 and 3) of Developing Diabetic Foot Ulcer
NCT ID: NCT05845242
Last Updated: 2023-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
80 participants
OBSERVATIONAL
2023-08-01
2028-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
LSCI and Thermography in Diabetic Foot Patients Affected by Ulcer(s): (MY-FOOT-B)
NCT05791929
Remote Temperature and Visual Monitoring To Help Manage Diabetic Foot Ulcers
NCT06782386
Treatment of Foot and Leg Ulcers Using a Laser
NCT03955289
3D Camera - Telemedical Foot Ulcer Treatment
NCT01870934
Prevalence of the Appearance of Diabetic Ulcers in Patients With 3D Insole and LSCI.
NCT05843929
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Even with great care, recurrent ulcers are common. To mediate the damage and societal costs that come with DF there is a need for applications to detect ulcers before they come apparent. To improve care, an application to predict the healing status is desired.
To this purpose, a set of four (4) specific clinical studies has been conceived to tackle the overall challenging objectives to characterise the risk of ulcers in different patients and through different measurement conditions, including conditions of how a tele-home care service can be deployed. This is clinical study A.
This study investigates two techniques:
Laser speckle contrast imaging (LSCI) is a promising non-invasive technique to assess microcirculation. LSCI, exploits the random speckle pattern that is generated when tissue is illuminated by laser light and changes when blood cells move in the sampled tissue.
Thermography is used to measure temperature distribution on the foot. It is expected that soon-to-be affected regions will be warmer than other regions. Also, regions with impaired blood supply can be recognized.
Clinical study A aims at determining Laser Speckle Contrast imaging and thermography features, the provocations that are needed to optimize imaging, and the correlation between these features and the IWGDF risk stratification category system for the diabetic foot.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Risk 0
Very low ulcer risk: No LOPS (loss of peripheral sensation) and No PAD (peripheral arterial disease)
No interventions assigned to this group
Risk 1
Low ulcer risk: LOPS or PAD
No interventions assigned to this group
Risk 2
Moderate ulcer risk: LOPS + PAD, or LOPS + foot deformity or PAD + foot deformity
No interventions assigned to this group
Risk 3
High ulcer risk: LOPS or PAD, and one or more of the following:
* history of a foot ulcer
* a lower-extremity amputation (minor or major)
* end-stage renal disease
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients above 18. Patients diagnosed with Diabetic feet.
* Patients with Risk Level 0, 1, 2 and 3 according to the International Working Group on the Diabetic Foot - IWGDF).
Exclusion Criteria
* Patients with active wounds on one or both feet.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Twente
OTHER
Ziekenhuisgroep Twente
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
KilianKappert
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kilian Kappert, PhD
Role: PRINCIPAL_INVESTIGATOR
ZGT
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZGT_MYFOOT_LSCI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.